Keyphrases
Discriminative Stimulus Effects
100%
Cocaine
70%
Ethanol Withdrawal
53%
Methamphetamine
50%
Rhesus Monkey
45%
Ethanol
42%
Locomotor
31%
Behavioral Effects
30%
3,4-methylenedioxymethamphetamine
30%
Locomotor Activity
27%
Antinociceptive
26%
Synthetic Cathinones
25%
Drug Discrimination
22%
Abuse Liability
21%
Pentylenetetrazole
21%
Synthetic Cannabinoids
20%
Δ9-tetrahydrocannabinol (Δ9-THC)
19%
Psychostimulants
18%
Dimethyltryptamine
18%
Discriminative Stimulus
18%
ED50
17%
Morphine
16%
Cathinones
16%
Carisoprodol
16%
Cathinone Analogs
15%
Hallucinogens
14%
MCPP
13%
Hyperalgesia
12%
Cannabinoids
12%
Rodents
12%
Behavioral Pharmacology
12%
Stimulants
12%
Heroin
11%
Sex Differences
11%
Dose Effect
11%
GABAA Receptor (GABAAR)
11%
Antinociception
11%
Amphetamine
10%
5-HT2C Receptor
9%
Antagonism
9%
Elevated Plus Maze
9%
High Dose
9%
Stimulatory Effect
9%
Opioid Antagonist
9%
Nicotine
9%
Open Arm
8%
Nociception
8%
μ-Opioid Receptor Agonist
8%
Sprague-Dawley Rats
8%
Response Rate
8%
Pharmacology, Toxicology and Pharmaceutical Science
Rhesus Monkey
45%
Cathinone
37%
Receptor
32%
MDMA
31%
Behavioral Effect
31%
Alcohol Withdrawal Syndrome
29%
Table Salt
27%
Cannabinoid
22%
Morphine
22%
2,5 Dimethoxy 4 Methylamphetamine
20%
Psychostimulant
20%
N,N-Dimethyltryptamine
20%
Sprague Dawley Rat
18%
Pentetrazole
18%
Tetrahydrocannabinol
18%
Hallucinogen
16%
Carisoprodol
16%
Hyperalgesia
14%
Antinociception
13%
Behavioral Pharmacology
13%
Adverse Event
12%
Mu Opiate Receptor Agonist
12%
Diamorphine
12%
Quadazocine
11%
4 [Alpha (4 Allyl 2,5 Dimethyl 1 Piperazinyl) 3 Hydroxybenzyl] N,n Diethylbenzamide
10%
Diazepam
9%
Meta-Chlorophenylpiperazine
9%
Cannabis
9%
Flumazenil
9%
Opiate
9%
4 Aminobutyric Acid
9%
4 Aminobutyric Acid A Receptor Blocking Agent
8%
Serotonin
8%
Nitrendipine
8%
Opiate Agonist
8%
Benzodiazepine
7%
Swiss Webster Mouse
7%
Lysergide
7%
Thermal Allodynia
7%
Tryptamine Derivative
7%
Bradykinin
7%
Benzofuran
7%
Naltrindole
7%
Psychotomimetic
6%
Theophylline
6%
Calcium Channel Blocker
6%
Barbiturate
6%
Duragesic
6%
Haplorhini
6%
Subjective Effects
6%
Neuroscience
Alcohol Withdrawal Syndrome
46%
Cathinone
26%
Dimethyltryptamine
19%
Morphine
19%
Nociception
17%
MDMA
16%
Carisoprodol
16%
Locomotor Activity
16%
Receptor
16%
Hyperalgesia
15%
Drug Discrimination
15%
Agonist
15%
Psychotomimetic
13%
Psychostimulant
12%
Pentylenetetrazol
11%
Meta-Chlorophenylpiperazine
11%
Heroin
11%
Tetrahydrocannabinol
11%
Behavioral Effect
11%
Analeptic
11%
GABAA Receptor
10%
Cannabinoid
9%
Behavior (Neuroscience)
9%
Serotonin
9%
Flumazenil
9%
Anxiogenic
9%
Lysergic Acid Diethylamide
8%
In Vitro
8%
Benzodiazepine
7%
Opiate
7%
5-HT2C Receptor
7%
Adverse Effect
7%
Theophylline
6%
Cannabis
6%
Conditioned Place Preference
6%
5-HT Receptor
6%
In Vivo
6%
Diazepam
6%
Meprobamate
6%
Elevated Plus Maze
6%
Nitrendipine
6%
Adenosine
5%
Behavioral Pharmacology
5%
Reuptake
5%
Mu-Opioid Agonists
5%
2,5-Dimethoxy-4-methylamphetamine
5%
Tryptamine
5%